Nimodipine 60mg/5ml oral suspension United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nimodipine 60mg/5ml oral suspension

special order - nimodipine - oral suspension - 12mg/1ml

Nimotop 0.02% w/v Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

nimotop 0.02% w/v concentrate for solution for infusion

bayer limited - nimodipine - concentrate for solution for infusion - 0.02 percent weight/volume - dihydropyridine derivatives; nimodipine

NYMALIZE- nimodipine solution United States - English - NLM (National Library of Medicine)

nymalize- nimodipine solution

azurity pharmaceuticals, inc. - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nymalize is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). none. risk summary there are no adequate data on the developmental risk associated with the use of nymalize in pregnant women. in animal studies, oral administration of nimodipine during pregnancy resulted in adverse effects on development (increased embryofetal mortality, increased incidences of fetal structural abnormalities, decreased fetal growth) at doses equivalent to (rat) or less than (rabbit) those used clinically [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. d

Nimotop 0.02% Solution for Infusion Malta - English - Medicines Authority

nimotop 0.02% solution for infusion

bayer plc - nimodipine - solution for infusion or injection - nimodipine 0.02 % (w/v) - calcium channel blockers

NIMODIPINO ALTAN 0.2 mg/ml solution for infusion Malta - English - Medicines Authority

nimodipino altan 0.2 mg/ml solution for infusion

ej busuttil ltd busuttil buildings, triq l-ghadam, central business district zone 1, birkirkara, cbd 1060, malta - solution for infusion - nimodipine 0.2 mg/ml - calcium channel blockers

Nimotop New Zealand - English - Medsafe (Medicines Safety Authority)

nimotop

bayer new zealand limited - nimodipine 30mg - film coated tablet - 30 mg - active: nimodipine 30mg excipient: crospovidone hypromellose iron oxide yellow macrogol 4000 magnesium stearate maize starch microcrystalline cellulose povidone titanium dioxide - after a preceding infusion of nimotop concentrated intravenous infusion solution, for:- prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm following subarachnoid haemorrhage of aneurysmal origin. patients should be in good neurological condition post-ictus.

Nimotop New Zealand - English - Medsafe (Medicines Safety Authority)

nimotop

bayer new zealand limited - nimodipine 0.2 mg/ml - solution for infusion - 0.2 mg/ml - active: nimodipine 0.2 mg/ml excipient: citric acid ethanol macrogol 400 sodium citrate dihydrate water for injection - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm following subarachnoid haemorrhage of aneurysmal origin. patients should be in good neurological condition post-ictus.

Nimotop 30 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

nimotop 30 mg film-coated tablets

bayer limited - nimodipine - film-coated tablet - 30 milligram(s) - dihydropyridine derivatives; nimodipine

Nimotop 30 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nimotop 30 mg tabl.

bayer sa-nv - nimodipine 30 mg - tablet - 30 mg - nimodipine 30 mg - nimodipine

Nimotop 10 mg/50 ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nimotop 10 mg/50 ml inf. sol. i.v.

bayer sa-nv - nimodipine 0,01 g/50 ml - solution for infusion - 10 mg - 50 ml - nimodipine 10 mg - nimodipine